BLCO insider trading
NYSE HealthcareBausch & Lomb Corp — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Bausch & Lomb Corp
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
Company website: www.bausch.com
BLCO insider activity at a glance
FilingIQ has scored 211 insider transactions for BLCO since May 5, 2022. The most recent filing in our index is dated May 5, 2026.
Across the full history, 12 open-market purchases
and 2 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on BLCO insider trades is 57.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for BLCO?
- FilingIQ tracks 211 Form 4 insider transactions for BLCO (Bausch & Lomb Corp), covering filings from May 5, 2022 onwards. 62 of those were filed in the last 90 days.
- Are BLCO insiders net buyers or net sellers?
- Across the full Form 4 history for BLCO, 12 transactions (6%) were open-market purchases and 2 (1%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does BLCO insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is BLCO in?
- Bausch & Lomb Corp (BLCO) is classified in the Healthcare sector, specifically Medical Instruments & Supplies, with a current market capitalisation of $6.35B.
Methodology & sources
Every BLCO insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.